1.29k likes | 1.49k Views
Plan For This Afternoon. IntroductionOverview of older person's mental disorders in primary careClinical Vignettes-Group WorkSpecialist Service and Primary care. GETTING OLDER. What does it mean to you?. GETTING OLDER. Direct Experience of Caring. Abilities that endure with ageing . Language co
E N D
1. OLD AGE PSYCHIATRY FOR PRIMARY CARE VOCATIONAL TRAINEES
Dr Nick Pearson
Consultant in the Psychiatry of Old Age Reading
040308
2. Plan For This Afternoon Introduction
Overview of older person’s mental disorders in primary care
Clinical Vignettes-Group Work
Specialist Service and Primary care
3. GETTING OLDER What does it mean to you?
4. GETTING OLDER Direct Experience of Caring
5. Abilities that endure with ageing Language comprehension and expression
Tip of the tongue states- word not immediately recalled but strong sense of knowing what that word is
Skills
Knowledge
Emotional states
Memory-cued recall better than free recall
New learning
Once learned remains
6. What improves with ageing? Improved problem solving
Use of more flexible strategies
Better able to keep calm in a crisis
7. Abilities that diminish with ageing Speed of thinking slows
Working memory reduced (remembering several things at any one time)
Episodic memory may be reduced (knowing exactly when, where, what and with whom)
8. Which brain areas are related to which tasks? Left inferior-lateral prefrontal-meaning of memory
Middle temporal lobe- binds episodic memory together
L insula-tip of the tongue states
Multiple areas including frontal, temporal & parietal-working memory
White matter connects different areas of brain together- ?executive function
Amygdala-emotion
9. Other ageing related effects Reorganisation into other brain areas within same hemisphere or opposite
Functions that were lateralised become bilateral
Less specialisation of function
Reduced dopamine related signalling
10. Cognitive functions may be able to adapt Adaptation does not mean less effective-just different
Adaptation may preserve function
11. Cerebrovascular Events Single large stroke or multiple strokes disrupt the reorganisation process
? Effect of small vessel disease-disruption to cognitive processes
12. Assisting Cognition in Normal Ageing Allow time
Presenting information singly
Spoken word-Improve comprehension by making meaning clear, avoid jargon
Written word-avoid ambiguity and more complex words as they require more processing
Older people respond better to positive stimuli
13. Stereotyping older people Up to ˝ of older people >65yrs believe they have a memory problem
The more you accept this view the more you seem to succumb to it
On memory testing if show older person negative word e.g. senile- perform badly
If positive word e.g. wisdom- perform well
Positive cultural view of ageing e.g. China people perform better on memory tests
14. Older Person’s Mental Disorders in Primary Care The terrific trio
Depression
Dementia
Delirium
15. Older Persons’ Depressive Disorders in Primary Care Depression in older age is not an inevitable consequence it is a pathological state
10-15% over 65yrs
GP list of 1700 20% > 65 yrs (340)
Depressed patients= 42
Treatment Resistant= 14
16. Older Person’s Depression in Primary Care 15-30% seek help
Prevalence Care homes 30-40%
Nursing homes 70%
General hospitals 15-20%
17. Older Persons’ Dementia in Primary Care Prevalence >65 yrs= 5%
Patients with dementia average GP caseload=17
>75yrs=10%
>85 yrs= 20%
>90yrs= 30%
Younger person with dementia-1
18. Older Persons’ Dementia in Primary Care Significant Behavioural and Psychological Symptoms in Dementia BPSD (30%)= 5
Mild to moderate (2/3) = 11
May benefit from treatment (3/4)= 8
19. Older Person’s Mental Disorders in Primary Care Younger onset dementia
1in 1000 < 65yrs
20. Older Persons’ Delirium in Primary Care Prevalence in primary care unknown
40% of>65yrs in hospital
21. Older Persons’ Psychotic Disorders in Primary Care Prevalence in community >65yrs of 1%
Schizophrenia
Persistent delusional disorders
Mania
Psychotic depression
22. Older Persons’ Psychotic Disorders in Primary Care for 65-86 yr olds over a 6 yr period mortality men 30% women 20%
Psychotic depression mortality men 75 % women 40%
23. Older Persons’ Neurosis in Primary Care Prevalence anxiety disorders>65yrs= 4%
Phobias= 10%
24. Older Persons’ Psychoactive Substance Use in Primary Care 4% of older males had drunk> 8 units of alcohol on at least 1 day in the previous week.
16-24yr olds?
Alcohol more commonly a complicating factor
25. Older Persons’ Mental Disorders in Primary Care: Factors Physical disorders
Medication
Social Context
Environmental Context
Individual’s meaning
26. CLINICAL CASE CaseStem1
CaseStem2
CaseStem3
27. Reading Old Age Psychiatry ServiceWhat are we aiming to do? Provide a specialist service for older people with mental health problems
Be Responsive
Be Flexible in our approach-needs led
Provide evidence based holistic care
Use latest technology where appropriate
Communicate effectively
Know what we do and how we can improve
Provide a service which is community focussed
28. Reading Old Age Psychiatry ServiceWhat do we do? Urgent treatment
Non urgent treatment
Recurrence/relapse prevention
Carer support and treatment
Specialist opinion e.g. complex Court of Protection issues
Service innovation e.g. www.roapi.net
Planning and audit
Research
29. Reading Old Age Psychiatry ServiceWhat do we do? Work with others- clinical, educational
primary care,
elderly medicine,
social services,
voluntary sector,
independent sector
GP forum
50+ forum
30. What do we not do? Provide social care
Keep people on case load indefinitely without good reason
Try not to foster dependency & production of psychiatric disorder
31. Reading Old Age Psychiatry ServiceHow do we do it? Home treatment team
CPN service
Day Hospital
Memory clinic
(Outpatients)
Inpatients
Liaison with acute trust, general psychiatry
Through a range of therapeutic options
32. Who is involved? Consultant, staff grade, GPSI psychiatrists
CPNs,
Occupational therapist,
Psychologist,
Speech and language therapy
Community support workers
Secretarial support
33. Which Patients? Older (using other older people’s services)
Frail
Complex medical/psychiatric
Older people with suspected dementia or cognitive impairment
Younger people with dementia-confirmed or highly probable
34. Patients Not to Refer Acute physical illness
Delirium
35. Supporting the Carers Listening
Informing
Involving
CBT for carers
Cognitive analytical therapy- dichotomies, ethical & moral considerations
36. Changing the Environment Housing for cognitively impaired
Safety issues
Aids and adaptations
Smart technology
Levels of sheltered accomodation
37. Social Care Social services
Voluntary Sector
Private Sector
38. Social Care Support for personal care
Help with shopping, housework
Mental Capacity Act
Lasting Power of attorney- welfare, health
Court of Protection
Allowances
Clubs, day care
39. Care Respite Care-at home or away
Long term care
Care homes DE
Nursing Homes DE
40. Delirium Worsens prognosis- significant mortality rate
Lengthens stay in hospital- longer in bed, falls, pneumonia
Increased rates of institutionalisation
Potentially treatable
Up to 2/3 not detected
41. Delirium: Clinical Features
Clouding of consciousness, attention, memory, executive function all affected
2 types
Apathetic
Active, psychotic, behavioural symptoms
Symptoms worse at night
42. Delirium:Risk Factors Increasing age
Dementia
Sensory deficits
Previous episode
Severe comorbidity
Immobility
Sleep Disturbance
Alcohol Consumption
Operation
Dehdration
Low albumin
43. Delirium-Medication Risk factors Benzodiazepines
Anticholinergics
Opiates
Digoxin
Warfarin
44. Delirium Causes Almost anything in combination with risk factors
45. Delirium-Tips
Sudden deterioration in mental state consider delirium
The greater the number of risk factors the more delirium is likely
Sometimes delirium can go on for weeks
46. Delirium:Treatment Identify and treat cause
Modify risk factors
Treat Infections, metabolic, malignancy, cardiac, vascular
Consider hospital admission
47. Delirium:TreatmentThe eight ates or Nice Coat Noise abate
Illuminate
Communicate
Environment manipulate
Carer participate
Orientate
Ambulate
Thermoregulate
48. Delirium:Medication If hyperactive and psychotic
Antipsychotic-haloperidol
Olanzapine, quetiapine
Lorazepam
49. Mild Cognitive Impairment (MCI)
Disputed entity
25% 0f community populations
Subjective and objective changes of cognitive impairment
Amnestic type
Vascular type
50. The Dementias: Clinical Features Progressive
Impairment of cognition, personality and intellect
Orientation,
Memory,
Language(dysphasia)
Ability to carry out tasks(praxias)
Recognition (agnosia)
Mood-prodromal depression
51. The Dementias-Executive Function Impairment Planning
Organising
Abstract thinking
Multi tasking
52. The Dementias: Behavioural and Psychological Symptoms in Dementia- BPSD Why are they important?
Predict carer distress and breakdown of supportive network
Predict institutionalisation
Nearly 90% of admissions to dementia ward
53. The Dementias: Behavioural and Psychological Symptoms in Dementia- BPSD Mood
Anxiety as a presentation
Anxiety as a concomitant
Depression as a precursor
Elation- often pre existing bipolar disorder
54. The Dementias: Behavioural and Psychological Symptoms in Dementia- BPSD Psychosis-delusions
Phantom lodger
Misidentifications e.g.Capgras
Persecutory
55. The Dementias: Behavioural and Psychological Symptoms in Dementia- BPSD-Psychosis Hallucinations
Auditory- music, voices
Visual-people, animals
56. The Dementias: Behavioural and Psychological Symptoms in Dementia- BPSD Wandering
Agitation
Day night reversal
Verbal Aggression
Physical Aggression
Disinhibition
Apathy
57. The Dementias: Causes Subdural
Brain tumour
Normal pressure hydrocephalus
Hypothyroidism
Low B12/folate
Syphilis
Diabetes
Chronic infection
Uraemia
58. The Dementias: Causes Alzheimer’s Disease(AD) 25%
Vascular Dementia(VaD) 10%
Mixed Dementia-Alzheimer’s with cerebrovascular disease AD/VaD 40%
Dementia with Lewy Bodies(DLB) 15%
Fronto Temporal Dementia (FTD) 5%
Others
59. Alzheimer’s disease Plaques (beta amyloid)
Tangles (hyperphosphorylated tau)
Insidious onset
Gradual decline
Memory (immediate & delayed recall), orientation difficulties early on
Later on dysphasia, dyspraxia, agnosia
60. Alzheimer’s with cerebro vascular disease Alzheimer’s +
Impairment of executive function early
Brings forward onset
61. Vascular Dementia Single large infarct
Multi infarct dementia
Subcortical dementia
Executive function impaired early
Some recall on delay
Visual & verbal memory differentially affected
Abrupt onset, step wise deterioration
62. Prevention and treatment of cognitive impairment and dementia Prevention:Reduce dementia incidence by ? 50%
Treatment: Improve cognition (and other function) once impaired- by how much?
63. Prevention and treatment of cognitive impairment and dementia Neuro protection
Neuronal reserve
Vascular risk factors
64. Prevention and treatment of cognitive impairment and dementia Which is your target population?
Prevention- general population
Healthy Middle aged people
Healthy Older people
Prevention- those at risk-vascular risk factors
Treatment- Older people with MCI
Treatment- Older people with dementia
65. Prevention and treatment of cognitive impairment and dementia Genetics
Chromosome 21-APOE4
Chromosome14 Pre senelin 1
Chromosome 1 Presenelin 2
Single Mutations in the above account for 10% of familial cases in early onset
Most older onset not accounted for by single genetic mutations
66. Prevention and treatment of cognitive impairment and dementia Alter Gene Expression in the Brain lifelong
Physical activity
Learning
Social
Improve neural connectivity
67. Neuroprotection Oxidative stress?free radicals?inflammation?vascular damage
Antioxidants. Vitamins C & E, alcohol.
Fruit & veg >5 portions per day
Fish 3x/week
Turmeric
Red wine Older Males< 10units/week, Older females,< 7 units/week
68. Neuroprotection Antiinflammatory
Alzheimer’s as an inflammatory disease
Non steroidal anti inflammatories?
Statins
Hyperhomocysteinaemia-vascular damage
Low levels of B12 & folate
Oestrogen?
69. Increase neuronal reserve Keep Active
Mental
Physical
Social
Leisure
70. aLive Mind Cognitive stimulation
Multi sensory stimulation
Lead in
Theme for the afternoon
‘Eating Well’ ‘Looking Good’
Patients and carers
Collaboration with voluntary sector
71. Vascular Risk Factors-Cerebro and cardiovascular Hypertension- what BP?
Hypotension-what BP?
TIAs- aspirin?
Diabetes-what control?
Ischaemic heart disease
Cardiac arrhythmias
Carotid atherosclerosis
Coronary artery bi pass grafting
Angioplasty
Metabolic syndrome
72. Vascular Risk Factors-Cerebro and cardiovascular Cholesterol increases beta amyloid
Hypercholesterolaemia-what cholesterol level?
Statins-reduce cholesterol, ? cerebral blood flow, ? ßamyloid, antiinflammatory
Smoking-vascular dementia
Obesity
73. Lewy Body-Parkinson’s disease spectrum disorder PD- Lewy Bodies in subcortex
Dementia with Lewy Bodies-cortex
Which comes first?
Alzheimer’s disease
PD and hallucinations from treatment
DAT scan
76. Dementia with Lewy Bodies Fluctuating course
Visual hallucinations
Spontaneous features of Parkinsonism
77. Dementia with Lewy Bodies Falls
Syncope
Systemised delusions
Hallucinations in other modalities
Neuroleptic sensitivity
78. Fronto Temporal Dementia 30% of younger onset dementia(45-65yrs)
Duration 8yrs
Overactive-disinhibted, lack of concern(orbitomedial frontal, anterior temporal)
Apathetic-perseveration, rigid thinking, lack of volition(pan frontal)
Stereotyped ritualistic behaviour(striatum)
Semantic dementia-unable to understand meaning of words, objects, sensations
Progressive non fluent dysphasia
79. Fronto Temporal Dementia Liking for sweet things
Emotional blunting
Striking loss of insight
Ability may be enhanced-artistic or musical
Tip-frontal lobe symptoms often precede memory problems
80. Other Dementias Subdural haematoma-history of fall
Creutzfeld-Jacob Disease-Classical-rapid decline, myoclonus, abnormal EEG, death in < 1 yr
Normal pressure hydrocephalus- cognitive change, gait abnormality, urinary incontinence
81. The Dementias: Identify and Diagnose History
Cognitive testing
Primary Care 6CIT MMSE
Physical examination
82. The Dementias: Dementia Screen FBC ESR
U&Es
LFT’s, Calcium, protein
Blood Sugar
Lipids
B12&folate
TFTs
Serological Tests for syphilis
ECG?
83. Referral to Old Age Psychiatry Early for diagnosis, comprehensive assesment
84. Dementias:Treatment Memory clinic
History
Examination
Investigation
Diagnosis
Treatment
85. Memory Clinic Patient and carer(s)
Detailed assessment and review
Mini Mental State Examination
Clock Drawing Test
Demtect
Executive Function
Bristol Activities of Daily Living
Peripatetic
86. Goals of Treatment Enhance Cognition
Increase autonomy
Decrease behavioural symptoms
Slow or arrest progression of the disease
Primary prevention in the presymptomatic stage
87. Memory Clinic- Work up for CHEIs Dementia screen
ECG-if pulse< 60/min
Neuropsychological testing-if MMSE>19
CT Brain scan
88. Treatment With A Cholinesterase Inhibitor (CHEI) Mild to moderate AD, AD with CVD, DLB
Carers opinion on progress
Good compliance
No contraindications
89. Treatment With A Cholinesterase Inhibitor (CHEI) Secondary Care Prescription
Donepezil
Rivastigmine
Galantamine
90. Memory Clinic Prescribe CHEI
Patient and carer information
www.roapi.net
Support or care at home
Monitoring and treatment of BPSD
Review 3/12 after stabilisation
91. Memory Clinic Review
Usually every 6/12
MMSE, CDT, EF, BADL, CGIC
Continue if evidence of benefit
92. Memory Clinic Stopping CHEIs
MMSE <12
Marked deterioration
No evidence of benefit
Taper over 2-4 weeks
Occasionally severe relapse- need to restart within 4/52
93. The Dementias:CHEIs Side effects-cholinergic-nausea, headache, sweating, bradycardia, dizziness
Cautions-asthma, sick sinus syndrome
Outcome
Actual improvement in behaviour cognition, function, psychosis
Slowing of deterioration
94. The Dementias: Treatment Memantine Licensed for moderate to severe dementia
Not supported by Priorities Committee in W Berks
Modest evidence of benefit in cognition, ADL, behaviour
95. The Dementias: Other Pharmacological Treatments Agitation, irritability, anxiety and verbal aggression
Trazodone 50mgs/day up to 250mgs day
Sedation, anticholinergic
Citalopram 10-20mgs/day up to 40mgs/day
palpitations., postural hypotension, confusion
Depression- antidepressant
96. The Dementias: Other Pharmacological Treatments Acute severe anxiety or agitation
Lorazepam 0.5 mgs up to tds
Respiratory depression, sedation, paradoxical agitation
Chronic agitation and restlessness-clomethiazole
97. The Dementias: Other Pharmacological Treatments Agitation, aggression-mood stabilisers
Sodium valproate 200mgs up to 1200mgs
Liver impairment, GI side effects, drowsiness or aggression
Carbamazapine 50mgs bd up to 1g/day
AV conduction defects,blurred vision. Dizziness, unstaediness GI side effects, confusion, agitation,, rash(Stevens Johnson), blood dyscrasia
98. The Dementias: Other Pharmacological Treatments Cholinergic deficit syndrome
Anxiety
Agitation
Hallucinations
CHEIs
99. The Dementias: Antipsychotics Psychotic symptoms, agitation, sexual disinhibition
Typicals:
Haloperidol 0.5mgs up to tds
Sedation, EPS
Benperidol: sexual disinhibition
100. The Dementias: Antipsychotics Atypicals
Quetiapine 25mgs/day up to 400mgs/day
sedation
Amisulpride 25mgs/day up to 300mgs/day
hypotension, sedation
Olanzapine 2.5mgs/day up to 20mgs/day
sedation weight gain, cves, mortality
Risperidone 0.5mg/day up to 2mgs/day
EPS,sedation, agitation, cves
Aripiprazole-DA partial agonist
101. The Dementias: Non Pharmacological Treatments -Reality orientation
Signposts
Notices
Memory aids
effective
102. The Dementias: Validation therapy Retreat into inner world to avoid stress, boredom & loneliness
Validation-empathy with feelings and hidden meanings behind the confusion
?Effective
103. The Dementias: Reminiscence May help social interaction, motivation, self care and reduce behavioural symptoms
At all severities of dementia
104. The Dementias: Art Therapy
Self expression through painting not relying on language
Stimulation, communication, social interaction
105. The Dementias: Music Therapy Active participation or listening
Social interaction
Can help those with abnormal vocalisations
Reductions in agitation for music tailored to individual
106. The Dementias: Activity Therapy Dance, drama. Sport
Physical activity, reduces falls, improves sleep, mood and confidence
Day time activity-reductions in agitation and restlessness at night
107. The Dementias:Complementary Therapies Massage,
Reflexology,
Herbal medicine
Efficacy not known
108. The Dementias: Aromatherapy Lavandula augustifolia melissa officianalis
Inhalation, bathing or topical
Reductions in agitation
Well tolerated
109. The Dementias: Light and Multisensory Bright Light Therapy
Beneficial in sleep disturbance
Multi Sensory Approaches
Fibreoptics, cushions& vibrating pads, liquid wheels
?improvements in agitation
110. The Dementias: Cognitive Behaviour Therapy
Early dementia
Misinterpretations, biases, distortions, erroneous problem solving strategies, communication problems
Benefit reported
CBT for carers
111. The Dementias: Interpersonal Therapy Individual distress within their own context
Person Centred Approach
Disputes, personality difficulties, bereavements, life evenst/changes
Little used in dementia
112. Depressive Disorder: Risk Factors
Disability
Handicap
Stroke
Parkinson’s disease
VaD
Heart Disease
COPD
113. Depressive Disorder- causative Physical Disorders Endocrine/Metabolic
Thyroid disorder
Cushings syndrome
Hypercalcaemia
Pernicious anaemia
Folate deficiency
114. Depressive Disorder- causative Physical Disorders Organic Brain disease
Cerebrovascular disease
CNS tumours
PD
AD
SLE
Occult Carcinoma
Pancreas
Lung
Chronic Infections
Neurosyphilis
Brucellosis
Herpes Zoster
115. Depressive Disorder-Medication causing Depression Antihypertensives: Beta blockers, methyl dopa, calcium channel blockers
Prednisolone
Analgesics: Codeine, opioids, COX2 inhibitors
AntiParkinsonian: L Dopa, amantadine, tetrabenazine
Psychotropics: antipsychotocs, benzodiazepines
116. Depressive Disorder-Detection History
Anorexia, weight loss and anergia difficult to interpret
Examination
Depression screen- FBC ESR, renal, liver, calcium, thyroid
GDS
117. Depressive Disorders- Treatment Remission of all residual symptoms
Provide appropriate Rx- NICE guidelines
antidepressants, psychological ECT
Provide info & support for patient/carers
118. Depressive Disorders- Treatment Optimise Function-
Rx physical conditions,
Attend to sensory deficits
Review medication
Enable Practical support
Sign posting to appropriate agencies
119. Depressive Disorders- Treatment Prevention of Relapse and Recurrence
Continue medication during recovery
Stay on medication for at least 1 yr after recovery
Maintenance treatment
Bipolar disorders-treatment for life
120. Depressive Disorders- Treatment Antidepressants- NNT of 4
SSRI-under 80yrs, avoid if patient taking aspirin NSAIDs, history of peptic ulcer
Over 80s-mirtazapine( sedation), venlafaxine (hypo or hypertension, cardiac disease), lofepramine
Moclobamide=MAOI B reversible
Phenelzine
All –low sodium-inappropriate ADH secretion
Discontinuation reactions- possible after 8 weeks
121. Depressive Disorders- Treatment Efficacy
TCA=venlafaxine> SSRIs
Often difficult to obtain a therapeutic dose of TCA
122. Depressive Disorders- Psychological Treatment Work in older people
CBT
Interpersonal therapy-relapse prevention
Problem solving
Psychoeducational techniques
Family therapy
In major depression-antidepressant + psychological Rx
123. Depressive Disorders- Treatment ECT
Severe depression 80% recover
Well tolerated
Broader spectrum of use
Not within 3/12 of stroke or heart attack
Memory impairment
124. Depressive Disorders- Treatment Rapid transcranial magnetic stimulation- research only
Exercise in prevention
Enhanced or stepped care- case mangement, antidepressants+ problem solving+ close links between primary & 2o care
125. Depressive Disorders- Treatment Resistant Depression
Medical cause for depression
Patient tolerates med
Compliance with medication
Proper dose
For long enough up to 8-12 weeks However recovery unlikely if no response within 4 weeks
126. Depressive Disorders- Treatment Resistance Substitute with another antidepressant (fewer interactions, easier to attribute success or failure or side effects)
Augmentation-( do not need to withdraw, possible synergy)
TCA with SSRI
SSRI+Mirtazapine
Antidepressant + Lithium
Up to 300mgs of venlafaxine
127. Depressive Disorders- MaintainanceTreatment Single episode major depression-1 yr after recovery
> 3episodes continue indefinitely at therapeutic dose
TCA, citalopram
Antidepressant+ psychological Rx
128. Depressive Disorders- Prognosis Thirds- 1/3 got better, 1.3 had relapses, 1/3 continuing sympotms
Better than this with active intervention-OAP-2/3 got better
Psychotic depression lethal- excess mortality from physical conditions
Increased risk of heart attacks and stroke
Vascular depression poor prognosis
129. Communication ROAPI- computerised patient care record including tabulated summary
Emails-quick, easy & written
Template for e referral on Balmore Pk EMIS
Bespoke Reading Old Age Psychiatry Web site: www.roapi.net